Skip to main content
Premium Trial:

Request an Annual Quote

Cellectricon Inks Japan Distribution Deals

NEW YORK (GenomeWeb News) – Cellectricon today said that it has signed agreement with two firms to distribute its products in Japan.

The Mölndal, Sweden-based firm said that Novel Science will distribute its Dynaflow Resolve System, an add-on to patch-clamp setups for ion channel research. Nepa Gene will distribute Cellectricon's Cellaxess ACE System, a single electrode-based electroporation system that can be used for any adherent cell type.

"We are confident that these two leading distributors will help us expand our research and drug discovery systems into the rapidly growing Japanese market," Mattias Karlsson, VP of business development at Cellectricon, said in a statement.

Financial and other terms of the agreements were not disclosed.

The Scan

Positive Framing of Genetic Studies Can Spark Mistrust Among Underrepresented Groups

Researchers in Human Genetics and Genomics Advances report that how researchers describe genomic studies may alienate potential participants.

Small Study of Gene Editing to Treat Sickle Cell Disease

In a Novartis-sponsored study in the New England Journal of Medicine, researchers found that a CRISPR-Cas9-based treatment targeting promoters of genes encoding fetal hemoglobin could reduce disease symptoms.

Gut Microbiome Changes Appear in Infants Before They Develop Eczema, Study Finds

Researchers report in mSystems that infants experienced an enrichment in Clostridium sensu stricto 1 and Finegoldia and a depletion of Bacteroides before developing eczema.

Acute Myeloid Leukemia Treatment Specificity Enhanced With Stem Cell Editing

A study in Nature suggests epitope editing in donor stem cells prior to bone marrow transplants can stave off toxicity when targeting acute myeloid leukemia with immunotherapy.